Pentylone

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by CheMoBot (talk | contribs) at 21:32, 1 September 2016 (Updating {{infobox_drug}} (changes to verified and watched fields) per Chem/infobox_drug validation (report errors or bugs)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Pentylone
Clinical data
ATC code
  • none
Legal status
Legal status
Identifiers
  • (±)-1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one
CAS Number
PubChem CID
ChemSpider
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC13H17NO3
Molar mass235.278 g/mol g·mol−1
3D model (JSmol)
  • c2cc1OCOc1cc2C(=O)C(NC)CCC
  • InChI=1S/C13H17NO3/c1-3-4-10(14-2)13(15)9-5-6-11-12(7-9)17-8-16-11/h5-7,10,14H,3-4,8H2,1-2H3 ☒N
  • Key:DFMLULIEUUXXSA-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

β-Keto-Methylbenzodioxolylpentanamine (Pentylone, βk-Methyl-K, βk-MBDP, methylenedioxypentedrone) is a stimulant compound developed in the 1960s,[1] which has been reported as a novel designer drug and identified in some samples of powders sold as "NRG-1", along with varying blends of other substituted cathinone derivatives including flephedrone, MDPBP, MDPV and 4-MePPP. It was also found in combination with 4-MePPP being sold as "NRG-3".[2]

Pharmacology

Pentylone acts as a serotonin-norepinephrine-dopamine reuptake inhibitor and weak serotonin releasing agent.[3]

Legality

Pentylone is an Anlage II controlled substance in Germany.

It is also illegal in Sweden.[4]

Pentylone is a Schedule I controlled drug in the US.[5]

See also

References

  1. ^ Substituted phenyl-α-amino ketones. British Patent GB 1085135 (1969).
  2. ^ Brandt SD, Freeman S, Sumnall HR, Measham F, Cole J (December 2010). "Analysis of NRG 'legal highs' in the UK: identification and formation of novel cathinones". Drug Testing and Analysis. 3 (9): 569–75. doi:10.1002/dta.204. PMID 21960541.
  3. ^ Simmler, L. D.; Rickli, A.; Hoener, M. C.; Liechti, M. E. (2014). "Monoamine transporter and receptor interaction profiles of a new series of designer cathinones". Neuropharmacology. 79: 152–60. doi:10.1016/j.neuropharm.2013.11.008. PMID 24275046.
  4. ^ "Cannabinoider föreslås bli klassade som hälsofarlig vara" (in Swedish). Retrieved 29 June 2015.
  5. ^ Schedules of Controlled Substances: Temporary Placement of 10 Synthetic Cathinones Into Schedule I